Please wait while the formulary information is being retrieved.
MUPIROCIN (mupirocin calcium)
- Impetigo
- Staph aureus traumatic skin lesion infection
- Traumatic skin lesion strep pyogenes infection
2 % topical ointment
- Apply a small amount to the affected area by topical route 3 times per day
2 % topical cream
- Apply a small amount to the affected area by topical route 3 times per day for 10 days
2 % topical ointment
- Apply a small amount to the affected area by topical route 3 times per day
Impetigo
- Apply a small amount to the affected area by topical route 3 times per day
- Apply a small amount to the affected area by topical route 3 times per day for 14 days
- Apply a small amount to the affected area by topical route 3 times per day for 5 days
Staph aureus traumatic skin lesion infection
- Apply a small amount to the affected area by topical route 3 times per day
- Apply a small amount to the affected area by topical route 3 times per day for 10 days
Traumatic skin lesion strep pyogenes infection
- Apply a small amount to the affected area by topical route 3 times per day
- Apply a small amount to the affected area by topical route 3 times per day for 10 days
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
MUPIROCIN (mupirocin calcium)
- Impetigo
- Staph aureus traumatic skin lesion infection
- Traumatic skin lesion strep pyogenes infection
- None
- Headache disorder
- Nausea
- Skin rash
More Frequent
Severe
Less Severe
- None
- Dry skin
- Erythema
- Pruritus of skin
- Skin inflammation
- Skin swelling
- Stinging of skin
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Clostridium difficile infection
Less Severe
- Acute abdominal pain
- Aphthous stomatitis
- Dizziness
- Pain
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Mupirocin (Topical)
Not recommended in infants less than 3 months
- 1 Day – 89 Days
- Not recommended in infants less than 3 months
Mupirocin
- Severity Level:
2
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Mupirocin
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Impetigo | |
| L01 | Impetigo |
| L01.0 | Impetigo |
| L01.00 | Impetigo, unspecified |
| L01.03 | Bullous impetigo |
| L01.09 | Other impetigo |
| L01.1 | Impetiginization of other dermatoses |
| Staph aureus traumatic skin lesion infection | |
| B95.6 | Staphylococcus aureus as the cause of diseases classified elsewhere |
| B95.61 | Methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B95.62 | Methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere |
| Traumatic skin lesion strep pyogenes infection | |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| 0-9 | A-Z |
|---|---|
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| B95.6 | Staphylococcus aureus as the cause of diseases classified elsewhere |
| B95.61 | Methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B95.62 | Methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere |
| L01 | Impetigo |
| L01.0 | Impetigo |
| L01.00 | Impetigo, unspecified |
| L01.03 | Bullous impetigo |
| L01.09 | Other impetigo |
| L01.1 | Impetiginization of other dermatoses |
Formulary Reference Tool